Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 27Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Busulfan 17Tacrolimus 16Whole-Body Irradiation 15Mycophenolic Acid 14Methotrexate 12Cyclosporine 12Antilymphocyte Serum 10Melphalan 7Filgrastim 7Etoposide 7fludarabine 6Radiotherapy 5Decitabine 5Carboplatin 5ruxolitinib 4Topotecan 4Methylprednisolone 4Flow Cytometry 4Cytarabine 4Thiotepa 3Imatinib Mesylate 3Cytogenetic Analysis 3Alemtuzumab 3veliparib 2merphos 2liposomal amphotericin B 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia Vera × Staining and Labeling × Other hematologic neoplasm × Clear all
NCT00052520 2017-03-29

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Fred Hutchinson Cancer Center

Phase 1/2 Completed
37 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡